caption stringlengths 6 2.51k | molecule stringlengths 1 747 | properties listlengths 1 86 |
|---|---|---|
The molecule is a energy storage, a emulsifier, a stabilizing cytochrome oxidase, and smooth. The molecule is a cholesterol translocation and a stabilizing mitochondrial structure that impacts diabetic heart disease, tangier disease, and non-alcoholic fatty liver disease. The molecule is a apoptosis, a energy source, and a membrane stabilizer, and it impacts aging. The molecule is a surfactant, food additive, nutritional supplement, proton trap for oxidative phosphorylation that impacts barth syndrome. | CCC(C)CCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCCC(C)C)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCC(C)C)OC(=O)CCCCCCCCC(C)CC | [
"Energy storage",
"Smooth",
"Emulsifier",
"Stabilizing cytochrome oxidase",
"Cholesterol translocation",
"Stabilizing mitochondrial structure",
"Diabetic heart disease",
"Tangier disease",
"Non-alcoholic fatty liver disease",
"Apoptosis",
"Aging",
"Energy source",
"Membrane stabilizer",
"s... |
The molecule is a membrane stabilizer and a nutrient, belonging to the anti oxidant class of molecules. The molecule is a energy storage, surfactant, emulsifier, energy source. | CC1=C(/C=C/C(C)=C/C=C/C(C)=C/C=C/C=C(C)/C=C/C=C(\C)CCC2=C(C)CC(O)CC2(C)C)C(C)(C)CC(O)C1 | [
"Membrane stabilizer",
"anti oxidant",
"nutrient",
"Energy storage",
"surfactant",
"Emulsifier",
"Energy source"
] |
The molecule is a energy storage, a membrane stabilizer, and a energy source, and it impacts non-alcoholic fatty liver disease. The molecule is a food additive, nutritional supplement, emulsifier that impacts diabetic heart disease and aging. The molecule is a apoptosis, proton trap for oxidative phosphorylation, cholesterol translocation, stabilizing mitochondrial structure. The molecule is a stabilizing cytochrome oxidase and a surfactant, which impacts both tangier disease and barth syndrome, and is characterized as smooth. | CCCCCC/C=C\C=C/CCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCC(C)C)OC(=O)CCCCCCCCC(C)CC)OC(=O)CCCCCCCCCCCCCCCCCCCCC(C)C | [
"Energy storage",
"Non-alcoholic fatty liver disease",
"Membrane stabilizer",
"Energy source",
"Diabetic heart disease",
"food additive",
"Nutritional supplement",
"Aging",
"Emulsifier",
"Apoptosis",
"Proton trap for oxidative phosphorylation",
"Cholesterol translocation",
"Stabilizing mitoc... |
The molecule is both a 5lipoxygenase inhibitor and a lipoxygenase inhibitor. | Cc1cc(C(C)N(O)C(N)=O)c(C)o1 | [
"5lipoxygenase inhibitor",
"lipoxygenase inhibitor"
] |
The molecule is a stabilizing mitochondrial structure and a stabilizing cytochrome oxidase that impacts barth syndrome, aging, and tangier disease. The molecule is a apoptosis, proton trap for oxidative phosphorylation, cholesterol translocation that impacts non-alcoholic fatty liver disease and diabetic heart disease. | CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCCCC)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCC/C=C\C/C=C\C/C=C\C/C=C\CC)OC(=O)CCC/C=C\C/C=C\C/C=C\C/C=C\CCCCC | [
"Barth syndrome",
"Aging",
"Stabilizing mitochondrial structure",
"Tangier disease",
"Stabilizing cytochrome oxidase",
"Non-alcoholic fatty liver disease",
"Apoptosis",
"Proton trap for oxidative phosphorylation",
"Diabetic heart disease",
"Cholesterol translocation"
] |
The molecule is a kinase modulator. | C=C(C)C(=NCc1ccc2ncccc2c1)NC(=CC)c1ccc2c(c1)C2=C | [
"kinase modulator"
] |
The molecule is a apoptosis and a proton trap for oxidative phosphorylation that impacts tangier disease, barth syndrome, and non-alcoholic fatty liver disease. The molecule is a stabilizing mitochondrial structure, cholesterol translocation, stabilizing cytochrome oxidase that impacts aging and diabetic heart disease. | CCCCCC/C=C\C=C/CCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCC)OC(=O)CCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCC(C)C | [
"Tangier disease",
"Barth syndrome",
"Apoptosis",
"Proton trap for oxidative phosphorylation",
"Non-alcoholic fatty liver disease",
"Stabilizing mitochondrial structure",
"Cholesterol translocation",
"Aging",
"Diabetic heart disease",
"Stabilizing cytochrome oxidase"
] |
The molecule is a proton trap for oxidative phosphorylation and a apoptosis that impacts aging, diabetic heart disease, and tangier disease. The molecule is a stabilizing mitochondrial structure, stabilizing cytochrome oxidase, cholesterol translocation that impacts barth syndrome and non-alcoholic fatty liver disease. | CCCCCCCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCCCCCCCCCC)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCC(C)C | [
"Aging",
"Diabetic heart disease",
"Proton trap for oxidative phosphorylation",
"Apoptosis",
"Tangier disease",
"Stabilizing mitochondrial structure",
"Barth syndrome",
"Stabilizing cytochrome oxidase",
"Non-alcoholic fatty liver disease",
"Cholesterol translocation"
] |
It has an effect on colorectal cancer, and impacts stomach cancer, breast cancer, and cardiovascular disease. It impacts seizure, alzheimer's disease, diabetes mellitus, and parkinson's disease. | CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCCCC(=O)OC[C@H](COP(=O)(O)O[C@H]1C(O)C(O)C(O)[C@@H](OP(=O)(O)O)C1O)OC(=O)CCC[C@@H](O)[C@H](O)/C=C\C=C/C=C/C=C/[C@@H](O)C/C=C\CC | [
"Stomach cancer",
"Breast cancer",
"Colorectal cancer",
"Cardiovascular disease",
"Seizure",
"Alzheimer's Disease",
"Diabetes mellitus",
"Parkinson's disease"
] |
The molecule is a stabilizing cytochrome oxidase, a surfactant, a energy storage, and smooth. The molecule is a apoptosis, stabilizing mitochondrial structure, membrane stabilizer, emulsifier that impacts non-alcoholic fatty liver disease. The molecule is a nutritional supplement and a energy source, impacting both tangier disease and diabetic heart disease. The molecule is a food additive, proton trap for oxidative phosphorylation, cholesterol translocation that impacts aging and barth syndrome. | CCC(C)CCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCC(C)CC | [
"Stabilizing cytochrome oxidase",
"Smooth",
"surfactant",
"Energy storage",
"Apoptosis",
"Stabilizing mitochondrial structure",
"Non-alcoholic fatty liver disease",
"Membrane stabilizer",
"Emulsifier",
"Nutritional supplement",
"Energy source",
"Tangier disease",
"Diabetic heart disease",
... |
The molecule is a nutrient, energy source, emulsifier, energy storage, surfactant, membrane stabilizer. | O=C(OCCc1ccccc1)c1ccccc1O | [
"nutrient",
"Energy source",
"Emulsifier",
"Energy storage",
"surfactant",
"Membrane stabilizer"
] |
The molecule is a cholesterol translocation, proton trap for oxidative phosphorylation, apoptosis that impacts diabetic heart disease and non-alcoholic fatty liver disease. The molecule is a stabilizing cytochrome oxidase and a stabilizing mitochondrial structure that impacts barth syndrome, tangier disease, and aging. | CC/C=C\C/C=C\C/C=C\C/C=C\CCCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCC)OC(=O)CCCC/C=C\C/C=C\C/C=C\C/C=C\CC | [
"Cholesterol translocation",
"Proton trap for oxidative phosphorylation",
"Diabetic heart disease",
"Non-alcoholic fatty liver disease",
"Apoptosis",
"Barth syndrome",
"Stabilizing cytochrome oxidase",
"Tangier disease",
"Aging",
"Stabilizing mitochondrial structure"
] |
It belongs to the diabetes treatment class of molecules. | CC(C)(C)c1ccc(C(O)c2c(C3=NCCN3)sc3ccccc23)cc1 | [
"diabetes treatment"
] |
The molecule is a 11βhsd1 inhibitor and a obesity treatment, belonging to the metabolic syndrome treatment class of molecules. | O=C(NC1C2CC3CC1CC(F)(C3)C2)N1CCCc2ccccc21 | [
"11βhsd1 inhibitor",
"obesity treatment",
"metabolic syndrome treatment"
] |
The molecule is a anti tumor and is anti biotic. | Cn1cc(NC(=O)OC(C)(C)C)nc1C(=O)Nc1ccc(-c2nc3ccc([N+](=O)[O-])cc3[nH]2)cc1 | [
"anti biotic",
"anti tumor"
] |
The molecule is a anti biotic. | CC(=O)C(C(=O)[O-])C(C)(C)C.[Na+] | [
"anti biotic"
] |
The molecule is a stabilizing mitochondrial structure that impacts diabetic heart disease, tangier disease, and aging. The molecule is a membrane stabilizer, cholesterol translocation, energy source that impacts barth syndrome and non-alcoholic fatty liver disease. The molecule is a emulsifier, a stabilizing cytochrome oxidase, a surfactant, and smooth. The molecule is a apoptosis, proton trap for oxidative phosphorylation, food additive, nutritional supplement, energy storage. | CCC(C)CCCCCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCC(C)C)OC(=O)CCCCCCCCC(C)CC)OC(=O)CCCCCCCCCCCCCCCCC(C)CC | [
"Diabetic heart disease",
"Tangier disease",
"Aging",
"Stabilizing mitochondrial structure",
"Barth syndrome",
"Membrane stabilizer",
"Cholesterol translocation",
"Non-alcoholic fatty liver disease",
"Energy source",
"Emulsifier",
"Smooth",
"Stabilizing cytochrome oxidase",
"surfactant",
"... |
The molecule is a stabilizing mitochondrial structure and a apoptosis that impacts aging, diabetic heart disease, and tangier disease. The molecule is a proton trap for oxidative phosphorylation, stabilizing cytochrome oxidase, cholesterol translocation that impacts non-alcoholic fatty liver disease and barth syndrome. | CC/C=C\C/C=C\C/C=C\CCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCC/C=C\C/C=C\CCCCC)COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCC/C=C\CCCCCCCC)OC(=O)CCC/C=C\C/C=C\C/C=C\C/C=C\CCCCC | [
"Aging",
"Diabetic heart disease",
"Stabilizing mitochondrial structure",
"Apoptosis",
"Tangier disease",
"Proton trap for oxidative phosphorylation",
"Stabilizing cytochrome oxidase",
"Non-alcoholic fatty liver disease",
"Cholesterol translocation",
"Barth syndrome"
] |
The molecule is a apoptosis, food additive, proton trap for oxidative phosphorylation, energy storage. The molecule is a surfactant and smooth, impacting tangier disease, aging, and barth syndrome. The molecule is a cholesterol translocation, a emulsifier, and a energy source, and it impacts non-alcoholic fatty liver disease. The molecule is a membrane stabilizer, nutritional supplement, stabilizing cytochrome oxidase, stabilizing mitochondrial structure that impacts diabetic heart disease. | CCC(C)CCCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCC(C)CC)OC(=O)CCCCCCCCCCCCCCC(C)C | [
"Apoptosis",
"food additive",
"Proton trap for oxidative phosphorylation",
"Energy storage",
"Tangier disease",
"Aging",
"surfactant",
"Barth syndrome",
"Smooth",
"Cholesterol translocation",
"Emulsifier",
"Energy source",
"Non-alcoholic fatty liver disease",
"Diabetic heart disease",
"M... |
The molecule is a cholesterol translocation and a stabilizing cytochrome oxidase that impacts aging, tangier disease, and diabetic heart disease. The molecule is a apoptosis, stabilizing mitochondrial structure, proton trap for oxidative phosphorylation that impacts non-alcoholic fatty liver disease and barth syndrome. | CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)O[C@H](COC(=O)CCCCCCC/C=C\C/C=C\CCCCC)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCC/C=C\C/C=C\CCCCC)OC(=O)CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCCC | [
"Cholesterol translocation",
"Aging",
"Tangier disease",
"Stabilizing cytochrome oxidase",
"Diabetic heart disease",
"Non-alcoholic fatty liver disease",
"Apoptosis",
"Stabilizing mitochondrial structure",
"Barth syndrome",
"Proton trap for oxidative phosphorylation"
] |
The molecule is a membrane stabilizer, energy source, energy storage, nutrient, emulsifier, surfactant. | CC(=O)/C=C\C(C)=C\C=C/C(C)=C/C=C/C=C(C)\C=C\C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C | [
"Membrane stabilizer",
"Energy source",
"Energy storage",
"nutrient",
"Emulsifier",
"surfactant"
] |
The molecule is a apoptosis, cholesterol translocation, proton trap for oxidative phosphorylation, stabilizing cytochrome oxidase that impacts barth syndrome. The molecule is a stabilizing mitochondrial structure that impacts aging, non-alcoholic fatty liver disease, tangier disease, and diabetic heart disease. | CCCCCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCCCCCCCC)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCC(C)C | [
"Apoptosis",
"Cholesterol translocation",
"Barth syndrome",
"Proton trap for oxidative phosphorylation",
"Stabilizing cytochrome oxidase",
"Aging",
"Non-alcoholic fatty liver disease",
"Stabilizing mitochondrial structure",
"Tangier disease",
"Diabetic heart disease"
] |
The molecule is a energy source and a fat storage that impacts thyroxine treatment, atherosclerosis, pancreatitis, and cancer. The molecule is a inflammatory and nutrient, and it impacts obesity. The molecule is a energy storage and a membrane stabilizer, impacting both metabolic syndrome and cardiovascular disease. | CCCCCCCCCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCC | [
"Thyroxine treatment",
"Energy source",
"Atherosclerosis",
"Pancreatitis",
"Cancer",
"Fat storage",
"Obesity",
"inflammatory",
"nutrient",
"Energy storage",
"Metabolic syndrome",
"Membrane stabilizer",
"Cardiovascular disease"
] |
The molecule is a apoptosis, stabilizing cytochrome oxidase, stabilizing mitochondrial structure that impacts aging and non-alcoholic fatty liver disease. The molecule is a cholesterol translocation and a proton trap for oxidative phosphorylation that impacts diabetic heart disease, tangier disease, and barth syndrome. | CCCCC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCC)COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCC/C=C\C/C=C\CCCCC)OC(=O)CCCCCCCCCCCCCCCCC | [
"Aging",
"Apoptosis",
"Non-alcoholic fatty liver disease",
"Stabilizing cytochrome oxidase",
"Stabilizing mitochondrial structure",
"Diabetic heart disease",
"Cholesterol translocation",
"Tangier disease",
"Proton trap for oxidative phosphorylation",
"Barth syndrome"
] |
The molecule is a nutrient. | CCCCC/C=C\C/C=C\C/C=C\CC1OC1CCCC(=O)OC[C@H](COP(=O)(O)OC[C@H](N)C(=O)O)OC(=O)CCCCCCC/C=C\CCCCCCCC | [
"nutrient"
] |
The molecule is a anti bacterial and is anti biotic. | CCCCc1ccc(-c2ccc(CC(=O)NCCC(=O)NC(CCCCNC(=O)OC(C)(C)C)C(=O)N(C)C3C(=O)NC(C)C(=O)NC(C(=O)OC)Cc4ccc(OC)c(c4)-c4cc3ccc4OC)cc2)cc1 | [
"anti biotic",
"anti bacterial"
] |
The molecule is organic light-emitting that impacts electron transport and has an effect on both low driving voltage and low voltage. | CCC1(C)c2cc3oc4ccccc4c3cc2-c2cccc(-c3cccc(-c4nc(-c5ccccc5)nc(-c5ccccc5)n4)c3)c21 | [
"electron transport",
"low driving voltage",
"low voltage",
"organic light-emitting"
] |
The molecule is both a cancer treatment and a ezh2 inhibitor. | Cc1c(C(=O)O)cc(Cl)c2c1OC(C)(C1CCN(C(=O)C3(C(F)(F)F)CC3)CC1)O2 | [
"cancer treatment",
"ezh2 inhibitor"
] |
The molecule is a nutrient and a membrane stabilizer that impacts atherosclerosis, cardiovascular disease, obesity, and thyroxine treatment. The molecule is a inflammatory that impacts both cancer and pancreatitis. The molecule is a energy storage, a fat storage, and a energy source, and it impacts metabolic syndrome. | CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COC(=O)CCCCCCCCCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCC | [
"nutrient",
"Atherosclerosis",
"Cardiovascular disease",
"Obesity",
"Membrane stabilizer",
"Thyroxine treatment",
"Cancer",
"inflammatory",
"Pancreatitis",
"Energy storage",
"Fat storage",
"Metabolic syndrome",
"Energy source"
] |
The molecule is a flavoring agent, fatty, waxy, and milky. The molecule is a nutrient, creamy, dairy, oil, sweet. | COc1ccc(-c2coc3cc(O)cc(O)c3c2=O)cc1OC1OC(CO)C(O)C(O)C1O | [
"fatty",
"waxy",
"milky",
"Flavoring agent",
"creamy",
"dairy",
"oil",
"sweet",
"nutrient"
] |
The molecule is a histone deacetylase inhibitor. | CC(C)(O)CN1CCC(Nc2cccc(N)c2)CC1 | [
"histone deacetylase inhibitor"
] |
The molecule is a stabilizing mitochondrial structure, cholesterol translocation, proton trap for oxidative phosphorylation that impacts tangier disease and non-alcoholic fatty liver disease. The molecule is a stabilizing cytochrome oxidase and a apoptosis that impacts aging, diabetic heart disease, and barth syndrome. | CCCCCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCCCCCCCC)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCC | [
"Tangier disease",
"Non-alcoholic fatty liver disease",
"Stabilizing mitochondrial structure",
"Cholesterol translocation",
"Proton trap for oxidative phosphorylation",
"Aging",
"Stabilizing cytochrome oxidase",
"Apoptosis",
"Diabetic heart disease",
"Barth syndrome"
] |
It belongs to the pain treatment class of molecules. | O=C(Nc1ccc(CF)cc1)N1CCC(F)(c2ncc(C(O)CO)cc2Cl)CC1 | [
"pain treatment"
] |
The molecule is a nutrient that affects breast cancer by impacting atherosclerosis, cervical cancer, and ulcerative colitis. | CC/C=C\C/C=C\CC(O)/C=C/C=C\C/C=C\CCCC(=O)O[C@H](COC(=O)CCCCCCC/C=C\CCCCCCCC)COP(=O)([O-])OCC[N+](C)(C)C | [
"nutrient",
"Atherosclerosis",
"Cervical cancer",
"Ulcerative colitis",
"Breast cancer"
] |
The molecule is a thrombin inhibitor and belongs to the anti coagulant class of molecules. | CC(C)C(NC(=O)C(NC(=O)C(CCCCNC(=O)OCc1ccccc1)NC(=O)NC(CCCN=C(N)N)C(=O)O)C(C)C)C(N)=O | [
"thrombin inhibitor",
"anti coagulant"
] |
The molecule is a cholesterol translocation and a apoptosis that impacts aging, barth syndrome, and tangier disease. The molecule is a stabilizing mitochondrial structure, proton trap for oxidative phosphorylation, stabilizing cytochrome oxidase that impacts diabetic heart disease and non-alcoholic fatty liver disease. | CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCCC)OC(=O)CCC/C=C\C/C=C\C/C=C\C/C=C\CCCCC)OC(=O)CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCCC | [
"Aging",
"Cholesterol translocation",
"Barth syndrome",
"Tangier disease",
"Apoptosis",
"Stabilizing mitochondrial structure",
"Proton trap for oxidative phosphorylation",
"Diabetic heart disease",
"Stabilizing cytochrome oxidase",
"Non-alcoholic fatty liver disease"
] |
The molecule is a protease inhibitor and belongs to the anti viral class of molecules. | O=C(CC(Cc1ccc(F)cc1)C(=O)O)c1ccc(-c2ccccc2)[nH]1 | [
"protease inhibitor",
"anti viral"
] |
The molecule is a cell adhesion inhibitor. | COc1cc(CC(=O)N2CCC(NC(=O)Nc3ccc(CC(=O)O)cc3)C2)ccc1NC(=O)Nc1ccccc1C | [
"cell adhesion inhibitor"
] |
The molecule is a stabilizing mitochondrial structure, cholesterol translocation, apoptosis that impacts diabetic heart disease and barth syndrome. The molecule is a stabilizing cytochrome oxidase and a proton trap for oxidative phosphorylation that impacts tangier disease, aging, and non-alcoholic fatty liver disease. | CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCC/C=C\CCCCCCCC)OC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCC/C=C\CCCCCCCC | [
"Stabilizing mitochondrial structure",
"Diabetic heart disease",
"Cholesterol translocation",
"Apoptosis",
"Barth syndrome",
"Tangier disease",
"Aging",
"Stabilizing cytochrome oxidase",
"Non-alcoholic fatty liver disease",
"Proton trap for oxidative phosphorylation"
] |
The molecule is a stabilizing cytochrome oxidase, apoptosis, stabilizing mitochondrial structure that impacts barth syndrome and non-alcoholic fatty liver disease. The molecule is a cholesterol translocation and a proton trap for oxidative phosphorylation that impacts aging, diabetic heart disease, and tangier disease. | CCCCCCCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCCCCCCCCC)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCCCCCCCCC | [
"Barth syndrome",
"Stabilizing cytochrome oxidase",
"Non-alcoholic fatty liver disease",
"Apoptosis",
"Stabilizing mitochondrial structure",
"Cholesterol translocation",
"Aging",
"Diabetic heart disease",
"Proton trap for oxidative phosphorylation",
"Tangier disease"
] |
The molecule is a apoptosis and a stabilizing cytochrome oxidase that impacts barth syndrome, diabetic heart disease, and non-alcoholic fatty liver disease. The molecule is a stabilizing mitochondrial structure, proton trap for oxidative phosphorylation, cholesterol translocation that impacts aging and tangier disease. | CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)O[C@H](COC(=O)CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCCC)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCC/C=C\C/C=C\CCCCC)OC(=O)CCC/C=C\C/C=C\C/C=C\C/C=C\CCCCC | [
"Apoptosis",
"Barth syndrome",
"Diabetic heart disease",
"Non-alcoholic fatty liver disease",
"Stabilizing cytochrome oxidase",
"Stabilizing mitochondrial structure",
"Aging",
"Proton trap for oxidative phosphorylation",
"Tangier disease",
"Cholesterol translocation"
] |
It belongs to the anti microbial class of molecules. | O=C(CCl)CC(=O)NC1C(=O)N2C(C(=O)O)=C(CSc3ncns3)CSC12 | [
"anti microbial"
] |
The molecule is a stabilizing mitochondrial structure, stabilizing cytochrome oxidase, cholesterol translocation that impacts aging and diabetic heart disease. The molecule is a proton trap for oxidative phosphorylation and a apoptosis that impacts barth syndrome, tangier disease, and non-alcoholic fatty liver disease. | CCCCCCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCCCC(C)C)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCCC | [
"Stabilizing mitochondrial structure",
"Aging",
"Stabilizing cytochrome oxidase",
"Cholesterol translocation",
"Diabetic heart disease",
"Barth syndrome",
"Tangier disease",
"Proton trap for oxidative phosphorylation",
"Apoptosis",
"Non-alcoholic fatty liver disease"
] |
The molecule is a neurological treatment. | CN(CCOc1ccc(-c2ccccc2)cc1C#Cc1ccccc1)CC(=O)OC(=O)C(F)(F)F | [
"neurological treatment"
] |
The molecule is a cholesterol translocation, stabilizing mitochondrial structure, apoptosis that impacts non-alcoholic fatty liver disease and tangier disease. The molecule is a stabilizing cytochrome oxidase and a proton trap for oxidative phosphorylation that impacts aging, diabetic heart disease, and barth syndrome. | CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCC(C)CC)OC(=O)CCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCCCCCC(C)CC | [
"Non-alcoholic fatty liver disease",
"Cholesterol translocation",
"Tangier disease",
"Stabilizing mitochondrial structure",
"Apoptosis",
"Stabilizing cytochrome oxidase",
"Aging",
"Diabetic heart disease",
"Proton trap for oxidative phosphorylation",
"Barth syndrome"
] |
The molecule is a flavoring agent, a nutrient, radish, turnup, and pungent. | COc1cc(C=O)cc(OC)c1Cl | [
"radish",
"turnup",
"pungent",
"Flavoring agent",
"nutrient"
] |
The molecule is a stabilizing cytochrome oxidase, apoptosis, stabilizing mitochondrial structure that impacts non-alcoholic fatty liver disease and barth syndrome. The molecule is a cholesterol translocation and a proton trap for oxidative phosphorylation that impacts aging, tangier disease, and diabetic heart disease. | CC/C=C\C/C=C\C/C=C\C/C=C\CCCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCCCCC)OC(=O)CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCCC)OC(=O)CCC/C=C\C/C=C\C/C=C\C/C=C\CCCCC | [
"Stabilizing cytochrome oxidase",
"Non-alcoholic fatty liver disease",
"Apoptosis",
"Stabilizing mitochondrial structure",
"Barth syndrome",
"Cholesterol translocation",
"Aging",
"Tangier disease",
"Diabetic heart disease",
"Proton trap for oxidative phosphorylation"
] |
The molecule is a cholesterol translocation, proton trap for oxidative phosphorylation, stabilizing mitochondrial structure that impacts non-alcoholic fatty liver disease and diabetic heart disease. The molecule is a stabilizing cytochrome oxidase and a apoptosis that impacts tangier disease, aging, and barth syndrome. | CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCC/C=C\CCCCCC)OC(=O)CCCCCCCCC/C=C\C/C=C\CCCCC)OC(=O)CCCCCCC/C=C\C/C=C\CCCCC | [
"Non-alcoholic fatty liver disease",
"Cholesterol translocation",
"Proton trap for oxidative phosphorylation",
"Diabetic heart disease",
"Stabilizing mitochondrial structure",
"Tangier disease",
"Aging",
"Stabilizing cytochrome oxidase",
"Barth syndrome",
"Apoptosis"
] |
The molecule is a fat storage, nutrient, inflammatory that impacts pancreatitis, obesity, and cardiovascular disease. The molecule is a membrane stabilizer and energy storage, and it impacts cancer. The molecule is a energy source that impacts thyroxine treatment, atherosclerosis, and metabolic syndrome. | CCCCCCCCCCCCCCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC(C)C | [
"Fat storage",
"Pancreatitis",
"nutrient",
"Obesity",
"inflammatory",
"Cardiovascular disease",
"Membrane stabilizer",
"Cancer",
"Energy storage",
"Thyroxine treatment",
"Energy source",
"Atherosclerosis",
"Metabolic syndrome"
] |
It has an effect on colorectal cancer, and impacts stomach cancer, parkinson's disease, and diabetes mellitus. It has an effect on breast cancer, and impacts cardiovascular disease, seizure, and alzheimer's disease. | CC/C=C\C/C=C\C/C=C\C/C=C\CCCCCCCCC(=O)OC[C@H](COP(=O)(O)O[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@H](O)[C@H]1O)OC(=O)CCCCCCCC(=O)/C=C/C=C\CCCCC | [
"Stomach cancer",
"Parkinson's disease",
"Colorectal cancer",
"Diabetes mellitus",
"Breast cancer",
"Cardiovascular disease",
"Seizure",
"Alzheimer's Disease"
] |
The molecule is a electronic device. | CC1(C)c2cc(-c3cccc4ccc5cccnc5c34)ccc2-c2ccc(-c3cccc4ccc5cccnc5c34)cc21 | [
"electronic device"
] |
The molecule is a proton trap for oxidative phosphorylation, apoptosis, cholesterol translocation that impacts barth syndrome and aging. The molecule is a stabilizing mitochondrial structure and a stabilizing cytochrome oxidase that impacts diabetic heart disease, tangier disease, and non-alcoholic fatty liver disease. | CCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCC(C)CC | [
"Proton trap for oxidative phosphorylation",
"Barth syndrome",
"Apoptosis",
"Aging",
"Cholesterol translocation",
"Diabetic heart disease",
"Tangier disease",
"Stabilizing mitochondrial structure",
"Non-alcoholic fatty liver disease",
"Stabilizing cytochrome oxidase"
] |
The molecule is a immunomodulator and pd1/pdl1 inhibitor, and it impacts cancer treatment. | Cc1c(COc2cc(OCc3cncc(C#N)c3)c(C=O)cc2Cl)cccc1-c1ccc2oc(C3CCN(C)CC3)nc2c1 | [
"immunomodulator",
"pd1/pdl1 inhibitor",
"cancer treatment"
] |
The molecule is a membrane stabilizer, a energy source, and a emulsifier, and it impacts non-alcoholic fatty liver disease. The molecule is a energy storage, a stabilizing cytochrome oxidase, and a surfactant, it impacts tangier disease and is smooth. The molecule is a cholesterol translocation that impacts diabetic heart disease, barth syndrome, and aging. The molecule is a proton trap for oxidative phosphorylation, stabilizing mitochondrial structure, food additive, apoptosis, nutritional supplement. | CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCC/C=C\CCCCCCCC)OC(=O)CCCCCCC/C=C\CCCCCCCC)OC(=O)CCCCCCCCCCCCCCC | [
"Membrane stabilizer",
"Energy source",
"Emulsifier",
"Non-alcoholic fatty liver disease",
"Tangier disease",
"Energy storage",
"Stabilizing cytochrome oxidase",
"surfactant",
"Smooth",
"Cholesterol translocation",
"Diabetic heart disease",
"Barth syndrome",
"Aging",
"Proton trap for oxida... |
The molecule is a cholesterol translocation that impacts aging, tangier disease, diabetic heart disease, and barth syndrome. The molecule is a stabilizing mitochondrial structure, stabilizing cytochrome oxidase, proton trap for oxidative phosphorylation, apoptosis that impacts non-alcoholic fatty liver disease. | CCCCCCCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCCCCC(C)C)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCC)OC(=O)CCCCCCCCCCC(C)CC | [
"Aging",
"Tangier disease",
"Diabetic heart disease",
"Barth syndrome",
"Cholesterol translocation",
"Stabilizing mitochondrial structure",
"Stabilizing cytochrome oxidase",
"Proton trap for oxidative phosphorylation",
"Apoptosis",
"Non-alcoholic fatty liver disease"
] |
The molecule is a apoptosis and a stabilizing mitochondrial structure that impacts aging, tangier disease, and non-alcoholic fatty liver disease. The molecule is a cholesterol translocation, stabilizing cytochrome oxidase, proton trap for oxidative phosphorylation that impacts barth syndrome and diabetic heart disease. | CCCCC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCC/C=C\C/C=C\CCCCC)OC(=O)CCCCCCC/C=C\CCCCCC)OC(=O)CCCCCCC/C=C\CCCCCC | [
"Aging",
"Apoptosis",
"Tangier disease",
"Stabilizing mitochondrial structure",
"Non-alcoholic fatty liver disease",
"Barth syndrome",
"Cholesterol translocation",
"Stabilizing cytochrome oxidase",
"Proton trap for oxidative phosphorylation",
"Diabetic heart disease"
] |
It belongs to the anti body class of molecules. | CCc1nc2c(N)nc3cccnc3c2n1CCCCNC(=O)c1ccc(NC)cc1 | [
"anti body"
] |
It belongs to the serotonin antagonist class of molecules. | CCCNC(=O)c1ccc(-c2cc3ccccc3c(N3CCN(CC)CC3)n2)cc1.Cl | [
"serotonin antagonist"
] |
The molecule is a chemokine receptor antagonist. | CC1(C)C=Cc2cccc(CN3CCC4(CCNC4)CC3)c2O1.Cl | [
"chemokine receptor antagonist"
] |
The molecule is a nutrient. | CCCCC/C=C\C/C=C\C/C=C\CCCCCCC(=O)O[C@H](COC(=O)CCC/C=C\C/C=C\C/C=C\C=C\[C@H](O)CCCCC)COP(=O)(O)OC[C@H](N)C(=O)O | [
"nutrient"
] |
The molecule is a stabilizing mitochondrial structure and a cholesterol translocation that impacts tangier disease, non-alcoholic fatty liver disease, and barth syndrome. The molecule is a proton trap for oxidative phosphorylation, apoptosis, stabilizing cytochrome oxidase that impacts diabetic heart disease and aging. | CCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCC | [
"Stabilizing mitochondrial structure",
"Cholesterol translocation",
"Tangier disease",
"Non-alcoholic fatty liver disease",
"Barth syndrome",
"Proton trap for oxidative phosphorylation",
"Diabetic heart disease",
"Aging",
"Apoptosis",
"Stabilizing cytochrome oxidase"
] |
The molecule is a immunomodulator and is cancer treatment. | Cc1c(COc2cc(OCc3cncc(C#N)c3)c(CNCc3cnccn3)cc2Cl)cccc1-c1cccc(OCCCN2CCC(O)C2)c1C | [
"cancer treatment",
"immunomodulator"
] |
The molecule is a apoptosis, proton trap for oxidative phosphorylation, stabilizing mitochondrial structure, cholesterol translocation that impacts tangier disease. The molecule is a stabilizing cytochrome oxidase that impacts non-alcoholic fatty liver disease, aging, barth syndrome, and diabetic heart disease. | CCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCC(C)CC | [
"Apoptosis",
"Tangier disease",
"Proton trap for oxidative phosphorylation",
"Stabilizing mitochondrial structure",
"Cholesterol translocation",
"Non-alcoholic fatty liver disease",
"Aging",
"Stabilizing cytochrome oxidase",
"Barth syndrome",
"Diabetic heart disease"
] |
The molecule is a cholesterol translocation, proton trap for oxidative phosphorylation, apoptosis, stabilizing mitochondrial structure that impacts tangier disease. The molecule is a stabilizing cytochrome oxidase that impacts barth syndrome, aging, non-alcoholic fatty liver disease, and diabetic heart disease. | CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCCCC(=O)O[C@H](COC(=O)CCCC/C=C\C/C=C\C/C=C\C/C=C\CC)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCC/C=C\C/C=C\CCCCC)OC(=O)CCCCCCC/C=C\C/C=C\CCCCC | [
"Cholesterol translocation",
"Proton trap for oxidative phosphorylation",
"Apoptosis",
"Stabilizing mitochondrial structure",
"Tangier disease",
"Barth syndrome",
"Aging",
"Stabilizing cytochrome oxidase",
"Non-alcoholic fatty liver disease",
"Diabetic heart disease"
] |
The molecule is a thyroxine treatment, energy storage, fat storage, inflammatory that impacts pancreatitis and cancer. The molecule is a membrane stabilizer and nutrient, and it impacts obesity. The molecule is a energy source that impacts cardiovascular disease, metabolic syndrome, and atherosclerosis. | CCCCCCCCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCC(C)C | [
"Thyroxine treatment",
"Energy storage",
"Fat storage",
"Pancreatitis",
"Cancer",
"inflammatory",
"Obesity",
"Membrane stabilizer",
"nutrient",
"Cardiovascular disease",
"Energy source",
"Metabolic syndrome",
"Atherosclerosis"
] |
The molecule is a apoptosis, a energy source, and a proton trap for oxidative phosphorylation, and it impacts non-alcoholic fatty liver disease. The molecule is a stabilizing mitochondrial structure, emulsifier, energy storage, membrane stabilizer that impacts aging. The molecule is a cholesterol translocation, a stabilizing cytochrome oxidase, and a food additive, and it impacts tangier disease. The molecule is a surfactant and a nutritional supplement, which impacts both diabetic heart disease and barth syndrome, and is characterized as smooth. | CC(C)CCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCC(C)C)COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCC(C)C | [
"Non-alcoholic fatty liver disease",
"Apoptosis",
"Energy source",
"Proton trap for oxidative phosphorylation",
"Stabilizing mitochondrial structure",
"Emulsifier",
"Energy storage",
"Membrane stabilizer",
"Aging",
"Cholesterol translocation",
"Stabilizing cytochrome oxidase",
"Tangier disease... |
The molecule is a membrane stabilizer and a energy source, it impacts barth syndrome, and is smooth. The molecule is a stabilizing cytochrome oxidase, proton trap for oxidative phosphorylation, cholesterol translocation that impacts tangier disease and non-alcoholic fatty liver disease. The molecule is a emulsifier and a food additive, impacting both diabetic heart disease and aging. The molecule is a stabilizing mitochondrial structure, apoptosis, energy storage, nutritional supplement, surfactant. | CC(C)CCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCC(C)C)OC(=O)CCCCCCCCC(C)C)OC(=O)CCCCCCCCCC(C)C | [
"Membrane stabilizer",
"Energy source",
"Smooth",
"Barth syndrome",
"Stabilizing cytochrome oxidase",
"Proton trap for oxidative phosphorylation",
"Cholesterol translocation",
"Tangier disease",
"Non-alcoholic fatty liver disease",
"Emulsifier",
"Diabetic heart disease",
"Aging",
"food addit... |
The molecule is a nutrient, fat storage, energy storage, inflammatory that impacts cardiovascular disease and obesity. This molecule is a member of the thyroxine treatment class, known to influence cancer and affect atherosclerosis. The molecule is a energy source and a membrane stabilizer, impacting both metabolic syndrome and pancreatitis. | CCCCCCCCCCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCCCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCC | [
"nutrient",
"Cardiovascular disease",
"Obesity",
"Fat storage",
"Energy storage",
"inflammatory",
"Thyroxine treatment",
"Cancer",
"Atherosclerosis",
"Energy source",
"Metabolic syndrome",
"Pancreatitis",
"Membrane stabilizer"
] |
The molecule is a anti biotic. | NCc1ccccc1CC(=O)NC1C(=O)N2C(C(=O)O)=C(CO)CS(=O)(=O)C12 | [
"anti biotic"
] |
The molecule is a lpxc inhibitor. | CCC(O)Cc1cc(CCC(C)(C(=O)OCc2ccccc2)S(C)(=O)=O)no1 | [
"lpxc inhibitor"
] |
The molecule is a asthma treatment member of the inflammatory disease treatment class. | CCCCCCCCCCCCCCOc1cc(Cl)c(OP(=O)(O)Oc2cccc(C[n+]3csc(C)c3)c2)cc1Cl | [
"asthma treatment",
"inflammatory disease treatment"
] |
The molecule is a nutrient that impacts obesity, cardiovascular disease, pancreatitis, metabolic syndrome, and atherosclerosis. The molecule is a thyroxine treatment and fat storage with an effect on cancer. The molecule is a energy storage, membrane stabilizer, energy source, inflammatory. | CCCCCCCCCCCC(=O)OC[C@H](COC(=O)CCCCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCC | [
"nutrient",
"Obesity",
"Cardiovascular disease",
"Pancreatitis",
"Metabolic syndrome",
"Atherosclerosis",
"Thyroxine treatment",
"Fat storage",
"Cancer",
"Energy storage",
"Membrane stabilizer",
"Energy source",
"inflammatory"
] |
The molecule is a nutrient and energy storage, belonging to the thyroxine treatment class of molecules, and impacts metabolic syndrome, obesity, and pancreatitis. The molecule is a energy source and fat storage, and it impacts cancer. The molecule is a membrane stabilizer and a inflammatory, impacting both atherosclerosis and cardiovascular disease. | CCCCCCCCCCCCC(=O)O[C@@H](COC(=O)CCCCCCCCCCCCCCCCCCCCC(C)CC)COC(=O)CCCCCCCCCCCCCCCCC(C)CC | [
"Metabolic syndrome",
"nutrient",
"Thyroxine treatment",
"Obesity",
"Energy storage",
"Pancreatitis",
"Energy source",
"Cancer",
"Fat storage",
"Atherosclerosis",
"Cardiovascular disease",
"Membrane stabilizer",
"inflammatory"
] |
The molecule is a energy source, a membrane stabilizer, and a proton trap for oxidative phosphorylation, and it impacts tangier disease. The molecule is a nutritional supplement, emulsifier, apoptosis that impacts diabetic heart disease and non-alcoholic fatty liver disease. The molecule is a surfactant, a food additive, and a energy storage, and it impacts aging. The molecule is a stabilizing mitochondrial structure, a stabilizing cytochrome oxidase, and a cholesterol translocation, it impacts barth syndrome and is smooth. | CCC(C)CCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCC(C)C)COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCC(C)C | [
"Energy source",
"Tangier disease",
"Membrane stabilizer",
"Proton trap for oxidative phosphorylation",
"Diabetic heart disease",
"Nutritional supplement",
"Emulsifier",
"Apoptosis",
"Non-alcoholic fatty liver disease",
"surfactant",
"food additive",
"Energy storage",
"Aging",
"Smooth",
... |
The molecule is thyroxine treatment and it impacts both cardiovascular disease and pancreatitis. The molecule is a fat storage and a nutrient, impacting both atherosclerosis and metabolic syndrome. | CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)OC[C@H](COC(=O)CCCCCCCCCCCCCCCCCCCCCCC)OC(=O)CCCC/C=C\C/C=C\C/C=C\C/C=C\CC | [
"Thyroxine treatment",
"Cardiovascular disease",
"Pancreatitis",
"Fat storage",
"nutrient",
"Atherosclerosis",
"Metabolic syndrome"
] |
The molecule is a apoptosis, a nutritional supplement, and a emulsifier, and it impacts diabetic heart disease. The molecule is a energy storage, a membrane stabilizer, and a proton trap for oxidative phosphorylation, it impacts non-alcoholic fatty liver disease and is smooth. The molecule is a food additive, energy source, stabilizing mitochondrial structure, surfactant. The molecule is a stabilizing cytochrome oxidase and a cholesterol translocation that impacts aging, tangier disease, and barth syndrome. | CCCCCC/C=C\C=C/CCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCC(C)C | [
"Diabetic heart disease",
"Apoptosis",
"Nutritional supplement",
"Emulsifier",
"Non-alcoholic fatty liver disease",
"Energy storage",
"Smooth",
"Membrane stabilizer",
"Proton trap for oxidative phosphorylation",
"food additive",
"Energy source",
"Stabilizing mitochondrial structure",
"surfac... |
It belongs to both the organic electroluminescent device and electroluminescent classes of molecules. | c1ccc(N(c2cc3c4ccccc4oc3c3ccccc23)c2cccc3c2oc2c(C4CCCCC4)cccc23)cc1 | [
"organic electroluminescent device",
"electroluminescent"
] |
The molecule is a food additive and a cholesterol translocation, it impacts aging, and is smooth. The molecule is a emulsifier, nutritional supplement, apoptosis that impacts tangier disease and diabetic heart disease. The molecule is a stabilizing cytochrome oxidase and a membrane stabilizer, impacting both non-alcoholic fatty liver disease and barth syndrome. The molecule is a energy storage, proton trap for oxidative phosphorylation, surfactant, stabilizing mitochondrial structure, energy source. | CC(C)CCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCC(C)C)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCC(C)C)OC(=O)CCCCCCCCCCCCCC(C)C | [
"Smooth",
"food additive",
"Cholesterol translocation",
"Aging",
"Emulsifier",
"Nutritional supplement",
"Tangier disease",
"Diabetic heart disease",
"Apoptosis",
"Stabilizing cytochrome oxidase",
"Membrane stabilizer",
"Non-alcoholic fatty liver disease",
"Barth syndrome",
"Energy storage... |
The molecule is a irritant, a food and nutrition, fruity, sweet, and banana. The molecule is a air pollutant, bitter, fragrance, laboratory chemical, solvent. | O=C(O)C(=O)C(=O)O | [
"irritant",
"Food and nutrition",
"fruity",
"sweet",
"banana",
"Air pollutant",
"bitter",
"fragrance",
"Laboratory chemical",
"solvent"
] |
The molecule is a nutrient. | COc1ccc2c([nH]c3c(-c4c(O)c(C)cc5c4[nH]c4c(C/C=C(\C)CCC=C(C)C)c(OC)ccc45)c(O)c(C)cc32)c1C/C=C(\C)CCC=C(C)C | [
"nutrient"
] |
It impacts both cancer treatment and hepatitis b treatment. | Cc1nc2cc(Br)ccn2c(=O)c1CNCC1CCC(=O)N1 | [
"cancer treatment",
"hepatitis B treatment"
] |
It impacts metabolic syndrome, cardiovascular disease, and atherosclerosis. The molecule is a nutrient and a fat storage, impacting both pancreatitis and thyroxine treatment. | CCCCC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)O[C@@H](COC(=O)CCCCCCC/C=C\CCCCCC)COC(=O)CCCCCCCCCCCCC/C=C\CCCCCCCC | [
"Metabolic syndrome",
"Cardiovascular disease",
"Atherosclerosis",
"nutrient",
"Pancreatitis",
"Fat storage",
"Thyroxine treatment"
] |
The molecule is both a kinase inhibitor and a hsp90 inhibitor. | CC1CC=CCCC=CC=Cc2c(Cl)c(O)cc(O)c2C(=O)O1 | [
"kinase inhibitor",
"hsp90 inhibitor"
] |
The molecule is a anti cancer, a estrogen receptor modulator, and anti cancer agent. | Cc1cc(C(C)(C)C)ccc1C1=C(c2ccc(OC3CCN(CCCF)C3)cc2)c2ccc(N)cc2CCC1 | [
"anti cancer",
"estrogen receptor modulator",
"anti cancer agent"
] |
The molecule is a cholesterol translocation, stabilizing cytochrome oxidase, stabilizing mitochondrial structure, apoptosis that impacts aging. The molecule is a proton trap for oxidative phosphorylation that impacts non-alcoholic fatty liver disease, tangier disease, diabetic heart disease, and barth syndrome. | CC/C=C\C/C=C\C/C=C\CCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCC/C=C\CCCCCCCC)OC(=O)CCC/C=C\C/C=C\C/C=C\C/C=C\CCCCC | [
"Cholesterol translocation",
"Aging",
"Stabilizing cytochrome oxidase",
"Stabilizing mitochondrial structure",
"Apoptosis",
"Proton trap for oxidative phosphorylation",
"Non-alcoholic fatty liver disease",
"Tangier disease",
"Diabetic heart disease",
"Barth syndrome"
] |
The molecule is anti tumor and anti mitotic. | O=C(O)c1c(-c2ccccc2)[nH]c2cc3c(cc2c1=O)OCO3 | [
"anti tumor",
"anti mitotic"
] |
It impacts cardiovascular disease, atherosclerosis, and pancreatitis. The molecule is a nutrient and fat storage, belonging to the thyroxine treatment class of molecules, and impacts metabolic syndrome. | CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCCCC(=O)OC[C@H](COC(=O)CCCCCCCCCCCCCC)OC(=O)CCCCCCCCC/C=C\C/C=C\CCCCC | [
"Cardiovascular disease",
"Atherosclerosis",
"Pancreatitis",
"nutrient",
"Metabolic syndrome",
"Thyroxine treatment",
"Fat storage"
] |
The molecule is a nutrient, membrane stabilizer, energy source, inflammatory that has an effect on cancer and impacts thyroxine treatment. The molecule is a fat storage and energy storage, and it impacts obesity. It impacts pancreatitis, atherosclerosis, metabolic syndrome, and cardiovascular disease. | CCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCC(C)CC | [
"Cancer",
"nutrient",
"Membrane stabilizer",
"Energy source",
"Thyroxine treatment",
"inflammatory",
"Obesity",
"Fat storage",
"Energy storage",
"Pancreatitis",
"Atherosclerosis",
"Metabolic syndrome",
"Cardiovascular disease"
] |
The molecule is a organic electroluminescent element and belongs to the electronic device class of molecules, with the characteristic of being electroluminescent. | c1cc(-c2cccc(N(c3ccc4sc5ccccc5c4c3)c3cc4ccccc4c4ccccc34)c2)cc(-c2cccc3ccccc23)c1 | [
"electronic device",
"electroluminescent",
"organic electroluminescent element"
] |
The molecule is a tyk2 inhibitor. | Cn1ccc(-c2cn(-c3cccc(F)c3F)c(=O)c3c(N)n[nH]c23)n1 | [
"tyk2 inhibitor"
] |
The molecule is a nutrient that is onion and horseradish. The molecule is garlic, pungent, sulfury, and vegetable. | O=C(/C=C/c1ccc(O)cc1)OCC1OC(OC2C(c3c(O)cc4oc(-c5ccc(O)c(O)c5)cc(=O)c4c3O)OC(CO)C(O)C2O)C(O)C(O)C1O | [
"nutrient",
"onion",
"horseradish",
"garlic",
"pungent",
"sulfury",
"vegetable"
] |
The molecule is a proton trap for oxidative phosphorylation, stabilizing cytochrome oxidase, stabilizing mitochondrial structure that impacts aging and non-alcoholic fatty liver disease. The molecule is a cholesterol translocation and a apoptosis that impacts barth syndrome, tangier disease, and diabetic heart disease. | CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCC)COP(=O)(O)OC[C@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCC/C=C\C/C=C\C/C=C\C/C=C\CC)OC(=O)CCC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CC | [
"Proton trap for oxidative phosphorylation",
"Aging",
"Stabilizing cytochrome oxidase",
"Stabilizing mitochondrial structure",
"Non-alcoholic fatty liver disease",
"Barth syndrome",
"Tangier disease",
"Cholesterol translocation",
"Apoptosis",
"Diabetic heart disease"
] |
The molecule is a pi3 kinase inhibitor. | CN1CCN(S(=O)(=O)c2cccc(Nc3cc(-c4cnc(N)nc4)nc(N4CCOCC4)n3)c2)CC1 | [
"pi3 kinase inhibitor"
] |
The molecule is a membrane stabilizer and a energy storage that impacts obesity, atherosclerosis, thyroxine treatment, and pancreatitis. The molecule is a inflammatory and energy source, and it impacts metabolic syndrome. The molecule is a fat storage and a nutrient, with effects on cancer and impacts on cardiovascular disease. | CCCCCCCCCCCCCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCCCCCCCCCC)OC(=O)CCCCCCC | [
"Obesity",
"Atherosclerosis",
"Membrane stabilizer",
"Energy storage",
"Thyroxine treatment",
"Pancreatitis",
"inflammatory",
"Metabolic syndrome",
"Energy source",
"Fat storage",
"nutrient",
"Cancer",
"Cardiovascular disease"
] |
The molecule is a stabilizing cytochrome oxidase, apoptosis, proton trap for oxidative phosphorylation that impacts barth syndrome and aging. The molecule is a stabilizing mitochondrial structure and a cholesterol translocation that impacts tangier disease, non-alcoholic fatty liver disease, and diabetic heart disease. | CCCCCCCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCC)COP(=O)(O)OC[C@@H](O)COP(=O)(O)OC[C@@H](COC(=O)CCCCCCCCCCC)OC(=O)CCCCCCCCC(C)CC | [
"Stabilizing cytochrome oxidase",
"Apoptosis",
"Proton trap for oxidative phosphorylation",
"Barth syndrome",
"Aging",
"Tangier disease",
"Non-alcoholic fatty liver disease",
"Stabilizing mitochondrial structure",
"Diabetic heart disease",
"Cholesterol translocation"
] |
It impacts alzheimer's treatment. | Cc1cc(C#N)cnc1OC1CCN(C(C)c2ccc3c(n2)OCCO3)CC1 | [
"alzheimer's treatment"
] |
The molecule is a liquid crystal display device. | CCOC(=O)Cc1ccc(N)cc1N | [
"liquid crystal display device"
] |
The molecule is a energy source that impacts diabetes mellitus type 2, inflammatory bowel disease, and cardiovascular disease. It impacts celiac disease, renal cell carcinoma, heart failure, and breast cancer. | CC=CC=CCCCCCCC(=O)OC(CC(=O)[O-])C[N+](C)(C)C | [
"Diabetes mellitus type 2",
"Energy source",
"Inflammatory bowel disease",
"Cardiovascular disease",
"Celiac disease",
"Renal cell carcinoma",
"Heart failure",
"Breast cancer"
] |
It belongs to the light-emitting class of molecules. | C=C(C=CC(=CC)N(c1ccccc1)c1ccccc1)c1cccc2c1-c1cc(-c3ccccc3)ccc1C21c2ccc(-c3ccc4c(c3)sc3ccccc34)cc2-c2c(-c3ccc(N(c4ccccc4)c4ccccc4)cc3)cccc21 | [
"light-emitting"
] |
The molecule is a acat inhibitor, a atherosclerosis treatment, and anti atherosclerotic. | CCCCCCCN(CCCCCSc1nc(-c2ccccc2)c(-c2ccccc2)[nH]1)C(=O)NC | [
"anti atherosclerotic",
"acat inhibitor",
"atherosclerosis treatment"
] |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.